Point72 Asset Management
JANX icon

Point72 Asset Management’s Janux Therapeutics JANX Stock Holding History

Point72 Asset Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1M Buy
1,156,140
+194,321
+20% +$2.66M 0.03% 933
2025
Q4 		$13.3M Sell
961,819
-748,381
-44% -$17.6M 0.02% 1173
2025
Q3 		$41.8M Sell
1,710,200
-433,700
-20% -$10.6M 0.09% 307
2025
Q2 		$49.5M Buy
2,143,900
+1,767,238
+469% +$46.6M 0.12% 251
2025
Q1 		$10.2M Sell
376,662
-244,721
-39% -$9.22M 0.03% 677
2024
Q4 		$33.3M Buy
621,383
+225,508
+57% +$11.9M 0.09% 315
2024
Q3 		$18M Buy
395,875
+259,445
+190% +$11.3M 0.06% 447
2024
Q2 		$5.72M Buy
+136,430
New +$6.41M 0.02% 797

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return